Biogen Sells Samsung Bioepis Stake In $2.3bn Buyout
Samsung Biologics To Take Full Ownership Of Biosimilars Joint Venture
• By David Wallace
Samsung Biologics has taken control of the biosimilars joint venture • Source: Dennis Diatel / Alamy Stock Photo 
